Our data suggests that SMTNL1 reduces the expression of MYPT1, the regulatory subunit of MP, in the presence of progesterone, and these changes are more prominent in the presence of progesterone and hyperglycemia (Figure 2A). Here, SMTNL1 is linked to Hyperglycemia.